home / stock / ctkb / ctkb news


CTKB News and Press, Cytek Biosciences Inc. From 01/15/26

Stock Information

Company Name: Cytek Biosciences Inc.
Stock Symbol: CTKB
Market: NASDAQ
Website: cytekbio.com

Menu

CTKB CTKB Quote CTKB Short CTKB News CTKB Articles CTKB Message Board
Get CTKB Alerts

News, Short Squeeze, Breakout and More Instantly...

CTKB - Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-15 01:45:59 ET Cytek Biosciences, Inc. (CTKB) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 8:15 PM EST... Read the full article on Seeking Alpha For further details see: Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare C...

CTKB - Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the fourth quarter and full year ended December 31, 2025. Cytek expects its total revenue for the full...

CTKB - Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth

2025-11-20 05:49:35 ET ... Read the full article on Seeking Alpha For further details see: Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth

CTKB - Biotech Surges as Programmable Cell Therapies Transform Chronic Disease Care

2025-11-18 08:42:02 ET Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies race to commercialize therapies that read, replace, and rew...

CTKB - TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026

FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking ...

CTKB - Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek ® Muse ® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The annual pr...

CTKB - Cytek Biosciences to Participate in Upcoming Investor Conferences

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Global Healthcare Conference in Palm Beach, FL Participati...

CTKB - Cytek reaffirms $196M-$205M 2025 revenue outlook as recurring businesses accelerate

2025-11-05 20:51:53 ET More on Cytek Biosciences Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) Cytek Biosciences: Growth Over Profit Will...

CTKB - Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

2025-11-05 20:51:11 ET Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

CTKB - Cytek Biosciences GAAP EPS of -$0.04 beats by $0.01, revenue of $52.3M beats by $1.16M

2025-11-05 17:19:42 ET More on Cytek Biosciences Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) Cytek Biosciences: Growth Over Profit Will Pay Off In The Long Term Seeking Alpha’s Quant Rating on...

Previous 10 Next 10